Back

Blockade of endothelial to mesenchymal transition (EndMT) by an inhibitor of histone methyltransferase EZH2 attenuates atherosclerosis in diabetes

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Targeting endothelial function Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Abdul Waheed Khan

Monash University, Melbourne (Australia)

8 More presentations in this session

Presentation thumbnail
Increased endothelial cell uptake of erythrocyte-derived extracellular vesicles carrying arginase-1 induces endothelial dysfunction in type 2 diabetes
Doctor A. Collado (Stockholm, SE)
Abstract Slides
Presentation thumbnail
SMAD3 silencing induces Epithelial-to-Mesenchymal Transition (EMT) towards cardiac pericyte progenitors with proangiogenic potential in hiPSC-derived epicardial cells
Doctor Y. Miyoshi (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Inhibition of ketohexokinase prevents fructose-induced insulin resistance and endothelial dysfunction in high fat and sucrose-fed mice via enhancing energy expenditure
Doctor H. Viswambharan (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Restoration of autophagy reduces diabetes-induced endothelial dysfunction
Doctor L. D'Ambrosio (Venafro, IT)
Abstract Slides
Presentation thumbnail
STING-mediated DNA damage response in diabetes-induced vascular complications
Ms O. Bavuu (Osaka, JP)
Abstract Slides

Access the full session

Session thumbnail
Targeting endothelial function

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources